|
Baxter (BAX) Receives FDA Guidance on Regulatory Pathway for New Peritoneal Dialysis Technology
StreetInsider.com Baxter International Inc. (NYSE: BAX), a global innovator in renal care, received guidance from the U.S. Food and Drug Administration (FDA) clarifying the regulatory pathway for an innovative, home peritoneal dialysis (PD) solution system to improve … |
May 03, 2017 at 07:12PM
from
No comments:
Post a Comment